Mackenzie Financial’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,319
| Closed | -$725K | – | 1581 |
|
|
2024
Q2 | $725K | Sell |
5,319
-208
| -4% | -$28.4K | ﹤0.01% | 926 |
|
|
2024
Q1 | $836K | Buy |
5,527
+1,072
| +24% | +$162K | ﹤0.01% | 916 |
|
|
2023
Q4 | $561K | Sell |
4,455
-198
| -4% | -$24.9K | ﹤0.01% | 968 |
|
|
2023
Q3 | $409K | Sell |
4,653
-353
| -7% | -$31K | ﹤0.01% | 1050 |
|
|
2023
Q2 | $441K | Sell |
5,006
-939
| -16% | -$82.8K | ﹤0.01% | 1054 |
|
|
2023
Q1 | $637K | Sell |
5,945
-467
| -7% | -$50.1K | ﹤0.01% | 954 |
|
|
2022
Q4 | $783K | Buy |
6,412
+733
| +13% | +$89.5K | ﹤0.01% | 811 |
|
|
2022
Q3 | $586K | Buy |
5,679
+1,384
| +32% | +$143K | ﹤0.01% | 897 |
|
|
2022
Q2 | $399K | Buy |
4,295
+1,393
| +48% | +$129K | ﹤0.01% | 991 |
|
|
2022
Q1 | $341K | Sell |
2,902
-5,124
| -64% | -$602K | ﹤0.01% | 1070 |
|
|
2021
Q4 | $1.08M | Sell |
8,026
-509
| -6% | -$68.5K | ﹤0.01% | 894 |
|
|
2021
Q3 | $1.36M | Sell |
8,535
-455
| -5% | -$72.5K | ﹤0.01% | 837 |
|
|
2021
Q2 | $1.18M | Sell |
8,990
-670
| -7% | -$88.2K | ﹤0.01% | 824 |
|
|
2021
Q1 | $1.25M | Buy |
9,660
+610
| +7% | +$78.6K | ﹤0.01% | 778 |
|
|
2020
Q4 | $1.51M | Buy |
9,050
+438
| +5% | +$73K | ﹤0.01% | 656 |
|
|
2020
Q3 | $1.33M | Buy |
8,612
+783
| +10% | +$121K | ﹤0.01% | 624 |
|
|
2020
Q2 | $1.16M | Sell |
7,829
-224
| -3% | -$33.1K | ﹤0.01% | 651 |
|
|
2020
Q1 | $907K | Sell |
8,053
-249
| -3% | -$28K | ﹤0.01% | 666 |
|
|
2019
Q4 | $1.16M | Sell |
8,302
-520
| -6% | -$72.3K | ﹤0.01% | 707 |
|
|
2019
Q3 | $850K | Buy |
8,822
+1,253
| +17% | +$121K | ﹤0.01% | 744 |
|
|
2019
Q2 | $872K | Buy |
+7,569
| New | +$872K | ﹤0.01% | 770 |
|